Search

everythinglearnresearchcommunity

for

Search:↓

Scarring alopecias are complex hair loss disorders that require early treatment to prevent permanent hair loss.

Accurate diagnosis is key for treating different kinds of hair loss, and immune response variations may affect the condition and treatment results.

Targeted cancer therapies often cause skin problems that need careful management to improve patient quality of life and treatment success.

The conclusion is that we need more effective hair loss treatments than the current ones, and these could include new drugs, gene and stem cell therapy, hormones, and scalp cooling, but they all need thorough safety testing.

pH, calcium, and reactive oxygen species regulate plant cell growth, with key roles for NADPH oxidases and plasma membrane H+-ATPases.

Early diagnosis and treatment are crucial for preventing permanent hair loss in various scalp conditions, and while new treatments are promising, more research is needed to evaluate their effectiveness.

Fractional resurfacing is safe and effective for certain skin conditions in Asian patients, but care must be taken to avoid skin pigmentation issues.

Different hair growth problems are caused by genetic issues or changes in hair growth cycles, and new treatments are being developed.

Oral zinc sulphate reduces dark hair color in mice.

Most hair loss in children is caused by a few common conditions, and it's important to diagnose these properly and support the child's mental health.

Hair disorders are caused by a complex mix of biology, genetics, hormones, and environmental factors, affecting hair growth and leading to conditions like alopecia.

New treatments for psoriasis have improved effectiveness and may reduce long-term side effects when combined with standard therapies.

Breast cancer patients taking CDK4/6 inhibitors are more likely to experience fatigue, hair loss, and mouth sores.

Cashmere and milk goats have different hair growth cycles and gene expressions, which could help improve wool production.

Cyclosporin A helps damaged hair follicles regrow hair quickly.

Interferons are effective for some skin conditions and cancers, but can have side effects and need more research for optimal use.

Alfredo Rebora suggested a new, easier way to classify hair loss in Telogen Effluvium, adding a type possibly related to autoimmune diseases.

Some drugs can cause skin and hair color changes, often reversible when the drug is stopped.

Teriflunomide effectively reduces relapses and disability in MS and has a manageable safety profile.

The document says that treating the root cause of hair follicle damage is crucial to prevent permanent hair loss, and treatment options vary.

Encapsulated Garcinia mangostana extract in cream penetrates skin better than other forms.

Using systemic drugs as creams for skin conditions shows promise, but more research is needed to confirm their effectiveness and safety.

People with Inflammatory Bowel Disease often lose hair due to stress, medication side effects, or lack of nutrients, and treatment depends on the specific cause.

Puberty often causes skin issues like acne and excessive sweating, and treatments require patience as results may vary.

Teriflunomide is an effective and safe first-line oral treatment for relapsing multiple sclerosis.

Hair follicles are essential for skin health, aiding in hair growth, wound healing, and immune function.

Liquorice may reduce testosterone and affect male reproductive organs, potentially helping treat conditions like prostate cancer.

AHCC reduces hair loss and liver injury caused by chemotherapy in rodents.

The paper suggests that telogen effluvium, a type of hair loss, may be a long-lasting condition triggered by stress or illness in people whose hair growth is unusually synchronized.

The document concludes that DAB389-IL2 is promising for treating refractory cutaneous T-cell lymphoma, but more research is needed on its effectiveness and side effect management.